Absolute quantitation of specific mRNAs in cell and tissue samples by comparative PCR.
A comparative PCR assay, for the absolute quantitation of specific mRNAs in cell and tissue samples, has been designed to overcome problems with previous techniques. cDNAs made from the RNAs are co-amplified with "competitor" plasmid templates under conditions in which reagents are not limiting at the equivalence point, thereby preventing competition between target and competitor templates and distinguishing the assay from competitive PCR assays. The cDNAs are serially diluted, and competitor templates concentrations are kept constant, rather than vice versa, as occurs in competitive PCR assays. Products from target and competitor templates are resolved by electrophoresis and measured by phosphorescent or fluorescent imagery. Both products are measured to minimize errors in the competitor:target ratio. A synthetic external standard RNA is included in the tissue lysis solution and co-purified with endogenous mRNAs, thereby being subjected to identical losses of yield during subsequent procedures. The determination of the number of copies of external standard cDNA allows inefficiencies of RNA extraction and cDNA synthesis to be taken into account. Standard concentrations of plasmids containing the endogenous target sequences are also measured, so that corrections can be made for discrepancies due to unequal amplification of target and competitor sequences. These corrections, together with the use of an external standard and the PCR conditions chosen, allow for the accurate, specific and sensitive determination of the absolute number of mRNA copies in a sample.
Royal Prince Alfred Hospital, Camperdown, NSW, Australia.
A M
AM
Martorana
G
G
Zheng
F
F
Springall
H J
HJ
Iland
R L
RL
O'Grady
J G
JG
Lyons
D000818:Animals; D002138:Calibration; D018076:DNA, Complementary / Q000235:genetics; D004591:Electrophoresis, Polyacrylamide Gel; D005260:Female; D015972:Gene Expression Regulation, Neoplastic; D005987:Glyceraldehyde-3-Phosphate Dehydrogenases / Q000235:genetics; D020180:Heteroduplex Analysis; D008666:Metalloendopeptidases / Q000032:analysis / Q000235:genetics; D009363:Neoplasm Proteins / Q000235:genetics; D010957:Plasmids / Q000235:genetics; D016133:Polymerase Chain Reaction / Q000379:methods*; D012313:RNA / Q000235:genetics; D012333:RNA, Messenger / Q000032:analysis*; D051381:Rats; D017421:Sequence Analysis; D019714:Tissue Inhibitor of Metalloproteinases / Q000032:analysis / Q000235:genetics; D014407:Tumor Cells, Cultured
D018076:DNA, Complementary; D009363:Neoplasm Proteins; C034477:RNA primers; D012333:RNA, Messenger; D019714:Tissue Inhibitor of Metalloproteinases; D012313:RNA; D005987:Glyceraldehyde-3-Phosphate Dehydrogenases; D008666:Metalloendopeptidases